Vaccination as Immunotherapy in Hematologic Malignancies

J Clin Oncol. 2021 Feb 10;39(5):433-443. doi: 10.1200/JCO.20.01706. Epub 2021 Jan 12.

Authors

Jessica Liegel¹, Matthew Weinstock¹, Jacalyn Rosenblatt¹, David Avigan¹

Affiliation

¹ Beth Israel Deaconess Medical Center, Department of Medicine, Division of Hematology and Hematologic Malignancies, Harvard Medical School, Boston, MA.

PMID: 33434056
DOI: 10.1200/JCO.20.01706

No abstract available

Publication types

Review

MeSH terms

Cancer Vaccines / therapeutic use*
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Hematologic Neoplasms / immunology
Hematologic Neoplasms / therapy*
Humans
Randomized Controlled Trials as Topic
Vaccination / methods

Substances

Cancer Vaccines